SAIGroup’s Post

From Becker's Healthcare: "Generative artificial intelligence in healthcare is poised to grow by nearly $21 billion by 2032, PYMNTS reported Oct. 4." However, if you are interested in applying #GenAI *today,* check out Microsoft for Startups companies, Commerce.AI, Hyro, Pangaea Data, and ScienceIO. Additionally, they will all be at #HLTH2023 and are ready to show you how they are using #generativeAI in a productive, safe and secure manner. More details in the link in the first comment. 👇 Jay Acosta Aaron Bours Vibhor Gupta Will M. Bethany Cordes Vikas Arora Derek Haynes

Great panel at CAASA Start-Up Round-Up 2024 with Prathna Ramesh, Michael Branco and Ricky Mehra on the Gold Rush in #AI! Here's a summary of their talk: 🎲 Role of VCs in AI: Mike and Rick agreed that VCs are critical in sifting through the noise to find valuable investments. This involves rigorous due diligence, understanding the customer problems, and focusing on practical use cases of AI. VCs then derisk the ventures, for example, by introducing tier 1 customers, supporting the back office that the founders might not have cared about, and figuring out the right team to scale. Mike pointed out that founders might overlook business operations, particularly those from technical backgrounds. ⏳ Time Horizon and Growth Rate:  The panellists discussed the speeding up of investment horizons in recent years, even for traditional long-tail industries like telecommunications. They also emphasized the need for investors to stay ahead of emerging trends, focusing on what's coming in the next 12 to 18 months and how the future will roll out in 3 to 5 years. 📊 Data & Distribution: Prathna emphasized that data and distribution advantages are key to getting to market better, faster, and cheaper than competitors. It’s about being really good at execution and leveraging these strengths effectively. Rick discussed the challenge of proprietary data in healthcare, highlighting the potential of having a single dataset of longitudinal patient data to revolutionize the industry. The challenge is the outdated HIPAA and GDPR regulations, which must be updated to keep up with digital health advancements. 🏗️ Build vs. Use Existing Models: Mike discussed the efficiency of using existing models, such as Meta's published model with base datasets, to solve previously too challenging problems. He gave an example of using AI for weather forecasting for big events and how the amount of data needed to process was too big to handle before AI. ⚠️ Risks and Concerns:  Rick raised concerns about the potential existential risks posed by AI and the need to carefully consider its impact on humanity, especially in his space in healthcare. For example, misdiagnosing due to AI's black-box nature can be more problematic and cause more deaths than human error. It is crucial to evaluate if the AI system you're building is the right solution for the problem and at what risk. AI is the first time something more intelligent than humans might be created, so linear projections from past technologies like phones or the internet are inadequate. Rick stressed the importance of slowing down and spending time thinking about how AI will impact humanity. Very insightful panel! Thanks CAASA - Canadian Association of Alternative Strategies & Assets for the event! #investing #startup #tech

I really like this line from one of a16z Bio Health work, got me thinking: 💡 "Just like the internet completely transformed go-to-market for software companies, AI will transform go-to-market for healthtech companies." ⁉ As an investor working closely both with SaaS and with healthcare companies, I'm just wondering when exactly the mass scale momentum will arrive to the large players in the healthcare industry, as most of them are still not ready to embrace the needed underlying permise for it, very well-stated in the article: 🗝 "Go-to-market will be far easier because AI companies can sell “AI humans,” as opposed to fighting the uphill battle of selling software on which healthcare companies must train their overworked employees." 🏥 Most buyers still struggle to trust and embrace the AI-product provided by the start-ups, and feel good about the idea of 'AI humans'. We have to continue working hard on the regulatory environment, along with making AI-startup products truly easy- and seamless to integrate in our existing healthcare processes, along with strong demonstration of the product's benefits. 💖 Let's make strong advances in healthcare innovation happen, expect some successes already in 2024! :) We, at UNIQA Ventures have already placed some exciting bets in the HC AI space and will continue doing so in the coming months. 😉 🌟 Abi Global Health Ifeel - Humanising Growth 🌠 #healthcareinnovation #ai #saas #venturecapital #startup #healthcareforall

#GenAI is at an inflection point where organizations are in the early stages of recognizing its potential, but are yet to see it as a growth catalyst for business. How will its adoption influence the future? My colleague Stacy Janiak shares her thoughts on staying ahead in this transformative era as the momentum for GenAI builds. https://deloi.tt/3ugDGdA

💫 Is Gen AI finally providing the technical unlock for an industry traditionally burdened by repetitive tasks? In a recent interview with Sifted's Kai Nicol-Schwarz, EQT Ventures’ Naza Metghalchi delved into the promising digital health startups set to reshape the industry. 👋 Reach out to Naza if you’re building AI for bio and pharma to supercharge R&D, or looking at streamlining non clinical workflows to reduce the admin burden. 👇 Link to article below.

I've had the pleasure of working with Romesh since 2018, when we founded ConcertAI. Even with our modest beginnings, our goals were audacious -- to transform research and care through definitive data at scale and AI SaaS solutions for oncology research and care. While early stage entities always make pivot and shifts in their approaches, our Northstar remained the outcomes of patients, with a deep confidence in achieving our goals that came from Romesh's success in building more than 30 companies and leadership in the industry in bringing AI into multiple products. This CNBC article by Rebecca Fannin is a wonderful testament to Romesh, his work, and his determination to assure Gen AI solutions builds better businesses and new levels of value. #concertai #ai

The generative artificial intelligence (AI) market for healthcare is valued at more than $1 billion as of 2022, and it is projected to swell to nearly $22 billion by 2032. Technology giants, venture capitalists and private equity firms will play a significant role in that market, acting as investors, partners and innovators. #Medtech #ExecutiveSearch #Leadership #StantonChase

The generative artificial intelligence (AI) market for healthcare is valued at more than $1 billion as of 2022, and it is projected to swell to nearly $22 billion by 2032. Technology giants, venture capitalists and private equity firms will play a significant role in that market, acting as investors, partners and innovators. #ExecutiveSearch #Leadership #StantonChase

Want Insider Tips On Trending Tech Topics Like #AI? Our recent Deloitte Knowledge Sharing series attracted 20 AI companies from our dynamic community. Specialists from Deloitte demonstrated the latest client requirements, business models, and case references that emerged through their past experiences. Always proud to know how our extensive partnership network can be a centralised insights hub for startups to accelerate innovative solutions and commercial success. You can leverage our powerful partners. Don’t miss our next session on #ESG. REGISTER NOW!   stp.hk/48YCqeA #HKSTP #PropellingSuccess